JPRN-UMIN000027696
Recruiting
Phase 1
Dose finding study for deciding the optimal dose of fluorescein during probe based confocal endomicroscopy - Dose finding study of fluorescein for pCLE
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ational Cancer Center Hospital
- Enrollment
- 24
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Contraindication to biopsy. Patients who can not stop anticoagulants. Allergy to fluorescein. Patients who have the history of pheochromocytoma, malignant hypertension, severe heart failure, myocardial infarction that has occured with in 3 months, uncontrolled diabetes, severe pulmonary fibrosis, active interstitial pneumonia, uncontrolled infection. Pregnant. Others who are judged as inappropriate by medical doctors.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
The exploratory study to determine optimum dosing of Axitinib (tyrosine kinase inhibitor) with pharmacokinetic analysis for patients with metastatic renal cell carcinomaJPRN-UMIN000011147Department of Urology, Graduate School of Medicine, Yamaguchi University20
Not yet recruiting
Not Applicable
A clinical study to determine the optimal dose of WIN-1001X by evaluating its efficacy and safety in patients with early Parkinson’s diseaseDiseases of the nervous systemKCT0004536Medihelpline188
Completed
Not Applicable
Clinical dose-finding study to assess the effect of ABAlifeTM on postprandial blood glucose profile in prediabetic subjects: randomized, multicentric, double-blind, placebo-controlled, cross-over study with different dosages combined with a 12-weeks follow-up phasePre-DiabetesDRKS00026093Anton Hübner GmbH & Co. KG61
Completed
Phase 4
Intranasal ketamine for moderate to severe pain in children- a dose finding study.acute painmusculoskeletal injuryAnaesthesiology - Pain managementInjuries and Accidents - Other injuries and accidentsACTRN12612000012875Southern Health60
Completed
Phase 1
Dose-escalation safety of novel fungal beta-glucanshealthy adult individualsbeta-GlucansPolysaccharidesOligosaccharidesFungiClinical TrialSafetyDietary SupplementsDose-escalation studyTCTR20240705004Institute of Nutrition, Mahidol University18